Hydromorphone hydrochloride injection

DRUG2 trials

Sponsors

Fujian Cancer Hospital, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Conditions

Cancer PainRespiratory Insufficiency

Phase 2

The Evaluation of the Effectiveness and Safety of Nalbuphine Hydrochloride Injection for Analgesia in ICU Patients: A Multicenter, Randomized, Single-blinded, Parallel, Two-step Trial

RecruitingNCT06785571

Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyRespiratory Insufficiency

Start: 2023-08-30End: 2025-10-31Target: 204Updated: 2025-01-21

Phase 3

IV PCA With or Without Continuous Dose vs Oral Opioid to Maintain Analgesia for Severe Cancer Pain After Successful Titration

CompletedNCT04785768

Fujian Cancer HospitalCancer Pain

Start: 2021-07-01End: 2024-07-01Updated: 2025-05-22

Related Papers

Protocol for a multicenter, randomized, single-blind, non-inferiority trial comparing nalbuphine hydrochloride versus hydromorphone hydrochloride for analgesia in mechanically ventilated ICU patients

Frontiers in Pharmacology2026-04-28